Revive Therapeutics Data Access Plan Approved By The FDA; Partial Unblinded Data In Company Hands Jun 25, 2022
Revive Therapeutics Advances Inflammatory Liver Disorders Programs for Autoimmune Hepatitis and Liver Transplantation May 31, 2022
